"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital
about
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisPhysician and Patient Barriers to Breast Cancer Preventive TherapyThe National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trialPatient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Media messages about cancer: what do people understand?Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriersHow do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study.Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.Development of a brochure for increasing awareness of inherited breast cancer in black women.My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.Tamoxifen vs Raloxifene vs Exemestane for ChemopreventionPublic awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based study.Beliefs and attitudes about lung cancer screening among smokers.Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.Decision making for breast cancer prevention among women at elevated riskPatient decision aids for prevention and treatment of cancer diseases: are they really personalised tools?Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.Deleterious BRCA1/2 mutations in an urban population of Black women.Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.Exploring older women's approaches to cervical cancer screening.Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
P2860
Q26773464-6FE8C31E-FB2E-4DA9-BE93-96B3C3F631E6Q28072526-C35A40B6-B517-4F7D-A6C5-EA26568B6BDBQ28217652-8DB7F037-63E0-4205-A2EF-3A945E18C444Q30431831-6F21A5BE-AD27-4CCC-B25D-35917B396CB2Q33767120-4EA8CC7B-0086-45B6-ACDA-BD0A6EED19C9Q34164814-98B8D710-A83F-43F0-BF94-AE7DB07C12BEQ34351382-1B1FBD3D-8D4E-478F-9CC1-41C694F8B3DDQ35225559-C775DBB5-3A07-42CB-88FA-BE8C9C5B4559Q35812120-5EEF86F6-F171-4D07-AC5A-CC1D04075C94Q36110695-AFF12685-D360-4C32-BF7B-7C1AE419F65FQ36117814-84D94586-5F1A-4A88-8DC8-41CAF66FCE55Q37078706-F2686E06-61EF-4EBA-81AA-ABBF3D3101DDQ37091358-0B22670C-B6CE-43CA-998B-6EC81E464C69Q37097084-10F3150B-48A2-4A92-BFA1-7D4A94DD674EQ37316725-3BF83E29-94D4-4E8D-8178-0BF9C7E47A05Q37321587-333261DF-874C-4B6B-9622-3AB023AB161AQ37681706-CAEEAE71-99AD-409E-8D3F-2D66499C9071Q37690290-ED8FD219-E8F1-4008-9D2F-0D93A512552CQ37720955-A939CA85-27DD-4931-95E3-A5BF78A0C551Q38726472-58133C61-CF6F-4F3A-A742-4AD05FC04E08Q38727084-AF814955-C883-417A-9E3F-74E6C86918B0Q40303275-C46EBF56-7BE4-4621-880A-F24DF373C167Q41696217-2E42804F-5234-4454-8C33-562BAE1BEDD3Q46514665-4F2EB7EC-1778-4F2B-BD99-E5FB9735AFC2Q51837751-60681BFE-27A8-4A01-81D8-BF95B0F21189Q52801719-1B39E93D-5114-4763-8868-4721BB29C428
P2860
"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
"Why take it if you don't have ...... n choices at a public hospital
@ast
"Why take it if you don't have ...... n choices at a public hospital
@en
type
label
"Why take it if you don't have ...... n choices at a public hospital
@ast
"Why take it if you don't have ...... n choices at a public hospital
@en
prefLabel
"Why take it if you don't have ...... n choices at a public hospital
@ast
"Why take it if you don't have ...... n choices at a public hospital
@en
P2093
P2860
P1476
"Why take it if you don't have ...... n choices at a public hospital
@en
P2093
Diane S Lauderdale
Pamela S Ganschow
Talya Salant
P2860
P304
P356
10.1111/J.1525-1497.2006.00461.X
P577
2006-07-01T00:00:00Z
P5875
P6179
1001147708